Software - ANVISA Registration 80595310001
Access comprehensive regulatory information for Software in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80595310001 and manufactured by 3D-SHAPER MEDICAL S.L. The registration is held by ALFEMA DOIS MERCANTIL CIRÚRGICA LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including PHILIPS MEDICAL SYSTEMS NEDERLAND B.V., CARDIO SISTEMAS COMERCIAL E INDUSTRIAL LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
80595310001
25351108616202535
33761636000105
Company Information
Dates and Status
Jul 28, 2025
VIGENTE
09/18/2025 19:00:01
Software
OnDemand3D
CYBERMED, INC.
10064010268
May 20, 2019
Software
MOBIUS 3D
Not specified
10405410036
Aug 12, 2019
Software
MOBIUS 3D
VARIAN MEDICAL SYSTEMS, INC.
10405410036
Aug 12, 2019
Software
SYNAPSE 3D
FUJIFILM CORPORATION, MEDICAL SYSTEMS RESEARCH & DEVELOPMENT CENTER
80022060047
Dec 08, 2014
Software
4D VIEW
GE Healthcare Austria GmbH & Co OG
80071260320
Aug 18, 2014
Software
Calculadora VDZ-CDST
TAKEDA PHARMACEUTICALS U.S.A., INC.
80147410026
Sep 15, 2025
Software
P4C
DEDALUS ITALIA SPA
81806320006
Sep 15, 2025
Software
AFOOT AI
LOOKINSIDE SERVICOS E TECNOLOGIAS LTDA
83126510001
Sep 08, 2025
Software
MV PEP
MV SISTEMAS DE MEDICINA DIAGNOSTICA LTDA
80436840006
Sep 08, 2025
Software
Future Fertility Oocyte Software
FUTURE FERTILITY INC.
83084440002
Aug 18, 2025